Advisor Group Holdings »

Enliven Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $528k 10k 50.75
2026-03-31 $393k 10k 39.20
2025-12-31 $924 60 15.40
2025-09-30 $1.7k 85 20.47
2025-06-30 $3.0k 149 20.06
2024-03-31 $35k 2.0k 17.59
2023-12-31 $28k 2.0k 13.84
2023-09-30 $27k 2.0k 13.66
2023-06-30 $20k 1.0k 20.41